Seed Testing May Predict Levodopa Response in Parkinson’s
TL;DR: A 2026 medRxiv preprint found that alpha-synuclein seed-positive Parkinson’s patients had slower ON-medication motor progression, measured while usual Parkinson’s medication was active, and more sustained levodopa responsiveness than matched seed-negative patients. Key Findings 223 matched patients: The analysis compared 40 SAA-negative and 183 SAA-positive sporadic Parkinson’s patients from PPMI. ON-state progression diverged while medication …
